Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Metastatic prostate cancer presenting as a rapidly increasing gluteal muscle mass at an intramuscular injection site

Prostate cancer is the second commonest male cancer globally. However, diagnosis may be delayed or missed due to atypical presentations such as metastases to unusual sites. The axial skeleton, lymph nodes, and viscera are the common sites for prostate cancer metastasis with skeletal muscles being un...

Full description

Saved in:
Bibliographic Details
Format: Article
Published: 2022-02
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000njm a2000000a 4500
001 oai:repository.ui.edu.ng:123456789/12050
042 |a dc 
720 |a Olapade-Olaopa, O. E.  |e author 
720 |a Adebayo, A. S.  |e author 
720 |a Osobu, E.  |e author 
720 |a Ajani, M.  |e author 
720 |a Ogunlayi, S.  |e author 
720 |a Magbagbeola, O. A.  |e author 
720 |a Farinre, O. M.  |e author 
720 |a Ogunbiyi, O. J.  |e author 
720 |a Ogunlade, S. O.  |e author 
260 |c 2022-02 
520 |a Prostate cancer is the second commonest male cancer globally. However, diagnosis may be delayed or missed due to atypical presentations such as metastases to unusual sites. The axial skeleton, lymph nodes, and viscera are the common sites for prostate cancer metastasis with skeletal muscles being uncommonly affected, and until now there has been no report of metastasis to the gluteal muscles from the disease. We present the case of a 78-year-old man with no lower urinary tract symptoms who presented with a 2-year history of a right supra-gluteal mass at the site of an intramuscular injection hematoma/abscess that rapidly increased in size 5 months prior to presentation and an abnormal gait. CT and MRI scans were suggestive of a malignant mass (possibly a rhabdomyosarcoma) and enlarged multinodular prostate with bilateral lymphadenopathy. A biopsy of the gluteal mass confirmed metastatic adenocarcinoma with the colon or the prostate being possible primaries. His serum PSA was markedly elevated (3441 ng/ml) but his other tumor markers were normal. Prostate biopsies confirmed a Gleason 4+3=7 prostate cancer and ADT was commenced. He responded well and remains in good health 15 months into his treatment with a marked reduction in the size of his gluteal mass and a restoration of a normal gait. His serum PSA and Testosterone are presently 2.4 ng/ml and 0.3 mmol/L respectively. 
024 8 |a 2474-1647 
024 8 |a ui_art_olapade-olapade_metastatic_2022 
024 8 |a Clinics in Surgery - Urology 7(3420), pp. 1-4 
024 8 |a https://repository.ui.edu.ng/handle/123456789/12050 
653 |a Prostate cancer 
653 |a Atypical metastasis 
653 |a Gluteal mass 
653 |a Muscle injury 
653 |a Cancer imaging 
245 0 0 |a Metastatic prostate cancer presenting as a rapidly increasing gluteal muscle mass at an intramuscular injection site